Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men

Hypertension

Volumn 32, Issue 2, 1998, Pages 318-323

  Pedrinelli, Roberto ^a   Penno, Giuseppe ^a   Dell'Omo, Giulia ^a   Bandinelli, Simona ^a   Giorgi, Davide ^a   Di Bello, Vitantonio ^a   Nannipieri, Monica ^a   Navalesi, Renzo ^a   Mariani, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Albuminuria; Atherosclerosis; Capillary permeability; Hypertension, essential; Vascular diseases

Indexed keywords

ALBUMIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CAPILLARY PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GLUCOSE TOLERANCE; HUMAN; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; VASCULAR RESISTANCE;

EID: 0031843973     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.2.318     Document Type: Article

References (40)

1. Deckert T, Yokoyama H, Mathiesen E, Ronn B, Jensen T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen JS. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ. 1996;312:871-874.
2. Beilin J, Stanton KG, McCann VJ, Knuiman MW, Divitini ML. Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality. Aust N Z J Med. 1996;26:519-525.
3. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in nondiabetic subjects. Lancet. 1988;2:530-533.
4. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as a predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.
5. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation. 1995;91:831-837.
6. Gorgels WJMJ, Van der Graaf Y, Hjemdahl P, Kortlandt W, Collette HJA, Erkelens DW, Banga JD. Urinary excretion of high molecular weight β-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the Diagnostic Onderzoek Mammacarcinoom (DOM) cohort, Utrecht, Netherlands. Am J Epidemiol. 1995;142: 1157-1164.
7. Jensen JS, Borch-Johnsen K, Feldt-Rasmussen B, Appleyard M, Jensen G. Urinary albumin excretion and history of acute myocardial infarction in a cross-sectional population study of 2,613 individuals. J Cardiovasc Risk. 1997;4:121-125.
8. Agewall S, Persson B, Samuelsson O, Ljungman S, Herlitz H, Fagerberg B. Microalbuminuria in treated hypertensive men at high risk of coronary disease. J Hypertens. 1993;11:461-469.
9. Agrawal B, Berger A, Wolf K, Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens. 1996;14:223-228.
10. Ljungman S, Wikstrand J, Hartford M, Berglund G. Urinary albumin excretion: a predictor of risk of cardiovascular disease - a prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens. 1996;9:770-778.
11. Deckert T, Kofoed-Enevoldsen A, Norgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen T. Microalbuminuria: implications for micro- and macrovascular disease. Diabetes Care. 1992;15:1181-1191.
12. Nannipieri M, Pilo A, Rizzo L, Penno G, Rapuano A, Navalesi R. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care. 1995;18:1-9.
13. Parving HH. Microvascular permeability to plasma proteins in hypertension and diabetes mellitus in man: on the pathogenesis of hypertensive and diabetic microangiopathy. Dan Med Bull. 1975;22:217-233.
14. Pedrinelli R. Microalbuminuria in hypertension. Nephron. 1996;73: 499-505.
15. Parving HH, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res. 1973;32:643-651.
16. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana A, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13:1377-1390.
17. Kiekara O, Riekkinen H, Soimakallio S, Lansimies E. Correlation of angiographically determined reduction of vascular lumen with lower-limb systolic pressures. Acta Chir Scand. 1985;151:437-440.
18. Liao JK, Bettmann MA, Sandor T, Tucker JI, Coleman SM, Creager MA. Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with-atherosclerosis. Circ Res. 1991;68:1027-1034.
19. Hesse B, Parving HH, Lund-Jacobsen H, Noer I. Transcapillary escape rate of albumin and right atrial pressure in chronic congestive heart failure before and after treatment. Circ Res. 1976;39:358-362.
20. Parving HH, Jensen HAE, Westrup M. Increased transcapillary escape rate of albumin and IgG in essential hypertension. Scand J Clin Lab Invest. 1977;37:223-227.
21. Nannipieri M, Penno G, Rizzo L, Pucci L, Bandinelli S, Mattel P, Taddei S, Salvetti A, Navalesi R. Transcapillary escape rate of albumin in type II diabetic patients. Diabetes Care. 1997;20:1019-1026.
22. Norgaard K, Jensen T, Feldt-Rasmussen B. Transcapillary escape rate of albumin in hypertensive patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:57-61.
23. Nielsen FS, Rossing P, Gall MA, Smidt UM, Chen JW, Sato A, Parving HH. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. Scand J Clin Lab Invest. 1997;57: 427-434.
24. Sullivan JM, Prewitt RL, Josephs JA. Attenuation of the microcirculation in young patients with high-output borderline hypertension. Hypertension. 1983;5:844-851.
25. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwin AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71b-74b.
26. Hilsted J, Christensen NJ. Dual effect of insulin on plasma volume and transcapillary albumin transport. Diabetologia. 1992;35:99-103.
27. Catalano C, Muscelli E, Quinones A, Baldi S, Masoni A, Gibb I, Torffvit O, Seghieri G, Ferrannini E. Effect of insulin on systemic and renal handling of albumin in nondiabetic and NIDDM subjects. Diabetes. 1997;46:868-875.
28. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966;1:1336-1337.
29. Pedrinelli R. Microalbuminuria: a marker of systemic vascular damage? Nephrol Dial Transplant. 1997;12:379-381.
30. Pedrinelli R, Di Bello VA, Catapano G. Talarico L, Materazzi F, Santoro G, Giusti C, Mosca F, Melillo E, Ferrari M. Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients. Arterioscler Thromb. 1993;13:900-906.
31. Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1324-1329.
32. Hollenbeck CB, Chen N, Chen YDI, Reaven GM. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes. 1984;33:460-463.
33. Groop L, Ekstrand A, Foorsblom C, Widen E, Groop PH, Teppo AM, Eikkson J. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:642-647.
34. Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid intima-media thickness in nondiabetic and NIDDM subjects: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1997;28:1710-1716.
35. Pedrinelli R, Lindpaintner K, Dell'Omo G, Napoli V, Di Bello V, De Caterina R, Petrucci R. Urinary albumin excretion and atherosclerosis in essential hypertension. Clin Sci. 1997;92:45-50.
36. Anderson S, Garcia DL, Brenner BM. Renal and systemic manifestations of glomerular disease. In: Brenner BM, Rector FC, eds. The Kidney. Philadelphia. Pa: Saunders; 1991:1831-1843.
37. Parving HH, Nielsen FS, Bang LE, Smidt UM, Svendsen TL, Chen JW, Gall MA, Rossing P. Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia. 1996;39:1590-1597.
38. Thompson SG, Kienast J, Pyke SDM, Haverkate F, Van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332: 635-641.
39. Jaffe EA, Nachman RL. Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells. J Clin Invest. 1975;56: 698-702.
40. Pedrinelli R, Giampietro O, Carmassi O, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet. 1994,344:14-18.